Vibativ® receives marketing approval in china

Vibativ® is a life-saving antibiotic for pneumonia and serious skin infections approval in china paves the way for launch in world's second-largest market nashville, tenn. and shanghai , feb. 18, 2025 /prnewswire/ -- specialty pharmaceutical companies cumberland pharmaceuticals inc. (nasdaq: cpix) and sciclone pharmaceuticals (holdings) limited ("sciclone pharmaceuticals" or "sciclone") today announced the nmpa (national medical products administration) approval of cumberland's vibativ® (telavancin) injection in china.
CPIX Ratings Summary
CPIX Quant Ranking